Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Eli Lilly and Company (NYSE:LLY) showcased strong financial performance in its Q4 2023 Earnings Call, reporting a 20% revenue... Eli Lilly and Company (NYSE:LLY) showcased strong financial ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...

Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for ...

The 11 branded pharmaceuticals stocks we track reported a mixed Q4. As a group ... Founded in 1876, Eli Lilly (NYSE:LLY) is a global pharmaceutical company that develops and produces a wide ...

ProQR expects up to four clinical data readouts in 2025 and 2026, including data for AX-0810 in Q4 2025. ProQR has strategic partnerships with Eli Lilly and the Rett Syndrome Research Trust ...